Publications

Detailed Information

Status epilepticus associated with sertindole

DC Field Value Language
dc.contributor.authorSinn, D. I.-
dc.contributor.authorChu, K.-
dc.contributor.authorJung, K. H.-
dc.contributor.authorPark, K. I.-
dc.contributor.authorNam, H.-
dc.contributor.authorLee, S. K.-
dc.date.accessioned2009-12-24T05:52:13Z-
dc.date.available2009-12-24T05:52:13Z-
dc.date.issued2007-07-31-
dc.identifier.citationEur J Neurol. 2007 Aug;14(8):e12-3.en
dc.identifier.issn1468-1331 (Electronic)-
dc.identifier.urihttp://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=17661989-
dc.identifier.urihttps://hdl.handle.net/10371/22237-
dc.language.isoen-
dc.publisherWiley-Blackwellen
dc.subjectAnticonvulsants/therapeutic useen
dc.subjectAntipsychotic Agents/*administration & dosage/adverseen
dc.subjecteffects/pharmacokineticsen
dc.subjectBrain/drug effects/metabolism/physiopathologyen
dc.subjectBrain Chemistry/drug effects/physiologyen
dc.subjectDose-Response Relationship, Drugen
dc.subjectElectroencephalography/drug effectsen
dc.subjectFemaleen
dc.subjectHaloperidol/therapeutic useen
dc.subjectHumansen
dc.subjectImidazoles/administration & dosage/*adverse effects/pharmacokineticsen
dc.subjectIndoles/administration & dosage/*adverse effects/pharmacokineticsen
dc.subjectMiddle Ageden
dc.subjectPhenytoin/therapeutic useen
dc.subjectReceptor, Serotonin, 5-HT2C/antagonists & inhibitors/metabolismen
dc.subjectSchizophrenia/drug therapyen
dc.subjectSerotonin/metabolismen
dc.subjectSerotonin Antagonists/administration & dosage/*adverseen
dc.subjecteffects/pharmacokineticsen
dc.subjectStatus Epilepticus/*chemically induced/physiopathologyen
dc.subjectTreatment Outcomeen
dc.titleStatus epilepticus associated with sertindoleen
dc.typeArticleen
dc.identifier.doi10.1111/j.1468-1331.2007.01787.x-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share